BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Europabio - ECPv6.17.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.europabio.org
X-WR-CALDESC:Events for Europabio
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Brussels
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20210511T120000
DTEND;TZID=Europe/Brussels:20210511T130000
DTSTAMP:20210506T121206Z
CREATED:20210312T082225Z
LAST-MODIFIED:20210506T121206Z
UID:1571-1620734400-1620738000@www.europabio.org
SUMMARY:Taking health up a gear: value of advanced therapies
DESCRIPTION:Advanced therapies have ground-breaking therapeutic potential\, particularly in disease areas where there is an unmet medical need and available therapeutic options are absent or inadequate. These therapies can bring the possibility of a cure to life-threatening conditions with a one-off treatment\, thereby changing the paradigm of providing health and care to patients suffering serious\, rare or complex diseases. \n\n\n\nA breakthrough innovator in the area of rare diseases will explain the cutting-edge science behind gene therapies\, why they are considered so transformative\, and what promise they hold to addressing unmet patient needs. \n\n\n\nA leading developer of the most innovative cancer treatments – CAR-T cell-based therapies will explain the changing paradigm of providing health for cancer patients and how innovation will help achieve the objectives of Europe’s Beating Cancer Plan. \n\n\n\nThe webinar will also engage policy makers reflecting live on how EU policies can truly harness the ground-breaking potential of advanced therapies. \n\n\n\nSpeakers \n\n\n\nSara Cerdas MEP\, BECA \n\n\n\nDick Sundh\, Head of ACE (Australia\, Canada & Europe) at Kite Pharma\, a Gilead Company  \n\n\n\nDirk Vander Mijnsbrugge\, Vice President Medical Affairs Lead Rare Diseases International Developed Markets at Pfizer \n\n\n\nSimone Boselli\, Public Affairs Director at EURORDIS  \n\n\n\n \n\n\n\nAbout EuropaBio Advanced Therapies Series: \n\n\n\nThe EuropaBio Advanced Therapies series of events\, interviews\, and publications will engage policymakers\, regulators\, patients and their representatives\, developers\, and all relevant stakeholders to discuss how innovation in gene- and cell-based medicine can bring a transformative value for patients. \n\n\n\nThroughout 2021\, we invite you to join us on a journey of exploring the tremendous potential of advanced therapies by discussing the new treatment paradigms\, the future of research and development in this fast-moving space of bio-science\, as well as debating recommendations for improving the access of patients to these ground-breaking treatments and supporting advanced manufacturing\, to name a few. \n\n\n\nVIRTUAL EVENT \n\n\n\n\nREGISTER HERE
URL:https://www.europabio.org/event/taking-health-medicine-up-a-gear-value-of-advanced-therapies/
CATEGORIES:EuropaBio,Healthcare Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2021/03/Event-Banners-10.png
END:VEVENT
END:VCALENDAR